Metastatic Thymic Carcinoma on Restaging 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography

Overview

Journal Indian J Nucl Med

Specialty Nuclear Medicine

Date 2021 Mar 1

PMID 33642772

Authors

Alex Cheen Hoe Khoo

Soo Fan Ang

Affiliations

Soon will be listed here.

Abstract

Thymic carcinoma is a rare thymic epithelial cancer which is not only locally invasive but also highly aggressive disease. The prognosis for this cancer is poor and the surgery remains the mainstay of treatment. Thymic carcinomas have been shown to metastasize to the lymph nodes, lung, and liver. A 63-year old male who was successfully treated for thymic cancer in 2015, presented with metastatic disease recurrence to the spinal cord. We share interesting images of the spinal cord lesions as well as pituitary metastases that were incidentally detected on restaging 18F-fluorodeoxyglucose positron emission tomography-computed tomography.

References

Treglia G, Sadeghi R, Giovanella L, Cafarotti S, Filosso P, Lococo F . Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis. Lung Cancer. 2014; 86(1):5-13. DOI: 10.1016/j.lungcan.2014.08.008. View

Yang X, Zhuo M, Shi A, Yang S, Wang Z, Wu M . Optimal first-line treatment for advanced thymic carcinoma. Thorac Cancer. 2019; 10(11):2081-2087. PMC: 6825903. DOI: 10.1111/1759-7714.13181. View

Wei M, Kang D, Gu L, Qiu M, Zhengyin L, Mu Y . Chemotherapy for thymic carcinoma and advanced thymoma in adults. Cochrane Database Syst Rev. 2013; (8):CD008588. PMC: 6457691. DOI: 10.1002/14651858.CD008588.pub2. View

Khandelwal A, Sholl L, Araki T, Ramaiya N, Hatabu H, Nishino M . Patterns of metastasis and recurrence in thymic epithelial tumours: longitudinal imaging review in correlation with histological subtypes. Clin Radiol. 2016; 71(10):1010-1017. PMC: 5010483. DOI: 10.1016/j.crad.2016.05.007. View

Hsu C, Chan J, Yin C, Lee C, Chern C, Liao C . Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States. PLoS One. 2020; 14(12):e0227197. PMC: 6938371. DOI: 10.1371/journal.pone.0227197. View

Thomas A, Mena E, Kurdziel K, Venzon D, Khozin S, Berman A . 18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors. Clin Cancer Res. 2013; 19(6):1487-93. PMC: 3602145. DOI: 10.1158/1078-0432.CCR-12-2929. View

Jee T, Lee S, Kim H, Kim E, Eoh W . Spinal metastasis of thymic carcinoma as a rare manifestation: a summary of 7 consecutive cases. Korean J Spine. 2014; 11(3):157-61. PMC: 4206972. DOI: 10.14245/kjs.2014.11.3.157. View

Sung Y, Lee K, Kim B, Choi J, Shim Y, Yi C . 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med. 2006; 47(10):1628-34. View

Segreto S, Fonti R, Ottaviano M, Pellegrino S, Pace L, Damiano V . Evaluation of metabolic response with F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors. Cancer Imaging. 2017; 17(1):10. PMC: 5339950. DOI: 10.1186/s40644-017-0112-x. View

10.

Eng T, Fuller C, Jagirdar J, Bains Y, Thomas Jr C . Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys. 2004; 59(3):654-64. DOI: 10.1016/j.ijrobp.2003.11.021. View

11.

Kanayama S, Matsuno A, Nagashima T, Ishida Y . Symptomatic pituitary metastasis of malignant thymoma. J Clin Neurosci. 2005; 12(8):953-6. DOI: 10.1016/j.jocn.2004.11.020. View